Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €96.50 EUR
Change Today -0.431 / -0.44%
Volume 0.0
As of 3:01 PM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

zimmer holdings inc (ZIM) Snapshot

Open
€96.50
Previous Close
€96.93
Day High
€99.00
Day Low
€96.50
52 Week High
03/13/15 - €112.19
52 Week Low
08/8/14 - €70.60
Market Cap
19.6B
Average Volume 10 Days
34.8
EPS TTM
--
Shares Outstanding
203.3M
EX-Date
05/13/15
P/E TM
--
Dividend
€0.85
Dividend Yield
0.77%
Current Stock Chart for ZIMMER HOLDINGS INC (ZIM)

zimmer holdings inc (ZIM) Related Businessweek News

No Related Businessweek News Found

zimmer holdings inc (ZIM) Details

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. It offers orthopaedic reconstructive devices that restore function lost due to disease or trauma in joints comprising knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons for the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. The company also provides related surgical products, such as surgical supplies and instruments to aid in orthopedic surgical procedures and post-operation rehabilitation; and other healthcare related services. It primarily serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

10,000 Employees
Last Reported Date: 02/23/15
Founded in 1927

zimmer holdings inc (ZIM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $934.9K
President of Europe, Middle East and Africa
Total Annual Compensation: $597.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $426.0K
Compensation as of Fiscal Year 2014.

zimmer holdings inc (ZIM) Key Developments

Zimmer Holdings, Inc. Announces Management Changes

On June 24, 2015, Zimmer Holdings, Inc. completed its previously announced acquisition of Biomet, Inc. In connection with the closing of the Merger, James T. Crines, the company's Executive Vice President, Finance and Chief Financial Officer, stepped down from that position effective as of June 24, 2015. Mr. Crines will continue to be employed by the company until his retirement on August 3, 2015, following 20 years of service to the company. Also as previously announced, in connection with the closing of the Merger, Stephen H.L. Ooi, the company's President, Asia Pacific, stepped down from that position effective as of June 24, 2015. Mr. Ooi will continue to be employed by the company until his retirement on December 31, 2015, following 29 years of service to the company. In addition, in connection with the closing of the Merger, Derek M. Davis, the company's Vice President, Finance and Corporate Controller and Chief Accounting Officer was appointed Vice President, Global Integration of the company and will no longer serve in the role of principal accounting officer of the company, effective as of June 24, 2015. Effective upon the closing of the Merger, the company's board of directors appointed the following new executive officers: Daniel P. Florin, age 51, was appointed Senior Vice President and Chief Financial Officer of the company, succeeding Mr. Crines. Mr. Florin served as Senior Vice President and Chief Financial Officer of Biomet from June 2007 until the closing of the Merger. Prior to joining Biomet, Mr. Florin served as Vice President and Corporate Controller of Boston Scientific Corporation from 2001 until 2007. Tony W. Collins, age 46, was appointed Vice President, Corporate Controller and Chief Accounting Officer of the company, succeeding Mr. Davis. In connection with this appointment, Mr. Collins was designated as the company's principal accounting officer. Previously, Mr. Collins served as Vice President, Finance for Zimmer's Global Reconstructive Division and Global Operations organization.

Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Second Quarter of 2015; Revises Earnings Guidance for the Full Year 2015

Zimmer Biomet Holdings, Inc. provided earnings guidance for the second quarter of 2015. The company estimates second quarter 2015 constant currency revenue growth, excluding Biomet acquired revenue, to be in a range of 1.0% to 1.5%, or 1.5% to 2.0% on a billing day, constant currency basis. The company estimates second quarter 2015 adjusted, fully diluted earnings per share to be in a range of $1.55 to $1.58. The company revised its earnings guidance for the full year of 2015. For the full year 2015, constant currency revenue compared to pro forma 2014 revenues is now expected to increase between 1.5% and 2.0%. Previously, the company had estimated full-year constant currency revenue would increase between 1.5% and 2.5% over 2014 pro forma revenues. The company estimates fully diluted earnings per share to be in a range of $6.60 to $6.80.

Zimmer Holdings, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:00 AM

Zimmer Holdings, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:00 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Dan Florin, CFO.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZIM:GR €96.50 EUR -0.431

ZIM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $82.02 USD +1.13
Hospira Inc $88.95 USD +0.06
Intuitive Surgical Inc $486.29 USD +0.45
Smith & Nephew PLC 1,084 GBp -6.00
St Jude Medical Inc $73.03 USD -0.60
View Industry Companies
 

Industry Analysis

ZIM

Industry Average

Valuation ZIM Industry Range
Price/Earnings 27.5x
Price/Sales 4.0x
Price/Book 2.8x
Price/Cash Flow 27.6x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIMMER HOLDINGS INC, please visit www.zimmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.